|
Meditation experience is associated with increased cortical thickness
2005
|
observational cohort |
20 |
↑Supports
|
Meditation practitioners had greater cortical thickness in the prefrontal cortex and right anterior insula compared to controls, with the prefrontal difference most pronounced in older participants, and thickness in two regions correlated with meditation experience. |
|
Psychedelics Promote Structural and Functional Neural Plasticity
2018
|
laboratory study |
|
↑Supports
|
Serotonergic psychedelics robustly increased neuritogenesis and spinogenesis in the prefrontal cortex via TrkB, mTOR, and 5-HT2A signaling pathways. |
|
Neural correlates of attentional expertise in long-term meditation practitioners
2007
|
observational cohort |
|
↕Mixed
|
Brain activation in sustained attention regions showed an inverted u-shaped curve with meditation expertise, and experts showed less activation in discursive thought regions and more in response inhibition regions during distracter sounds. |
|
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.
2017
|
observational cohort |
19 |
↑Supports
|
Psilocybin treatment decreased amygdala cerebral blood flow and increased default-mode network connectivity, with specific connectivity changes predicting clinical response at five weeks. |
|
Functional Reorganization of the Default Mode Network across Chronic Pain Conditions
2014
|
observational cohort |
|
↓Opposes
|
Chronic pain was associated with decreased connectivity of medial prefrontal cortex to posterior default mode network regions and increased connectivity to insular cortex, with changes correlated to pain intensity and duration. |
|
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
2023
|
experimental study |
|
↑Supports
|
Intracellular 5-HT2ARs, not cell-surface ones, mediate the plasticity-promoting effects of psychedelics, explaining why serotonin does not engage similar plasticity mechanisms. |
|
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
2023
|
experimental study |
|
↑Supports
|
Psychedelics directly bind to TrkB with high affinity to produce antidepressant-like effects independently of serotonin 2A receptor activation. |
|
Increased global integration in the brain after psilocybin therapy for depression.
2022
|
open-label trial and double-blind phase II randomized controlled trial |
|
↑Supports
|
Psilocybin's antidepressant action correlated with global increases in brain network integration, as indicated by decreased fMRI brain network modularity. |
|
Cognitive-Affective Neural Plasticity following Active-Controlled Mindfulness Intervention
2012
|
randomized controlled trial |
|
↕Mixed
|
Mindfulness training reduced affective Stroop conflict and increased dorsolateral prefrontal cortex responses during executive processing, but only participants with the greatest amount of practice showed improvements in response inhibition and increased recruitment of anterior cingulate, medial prefrontal, and insular regions during negative valence processing. |
|
Emotions and brain function are altered up to one month after a single high dose of psilocybin.
2020
|
open-label pilot study |
12 |
↕Mixed
|
Psilocybin reduced negative affect and amygdala reactivity at one week, but negative affect and amygdala response returned to baseline at one month while positive affect remained elevated and resting-state functional connections increased. |
|
A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists
2012
|
review |
|
↑Supports
|
Ketamine rapidly induces synaptogenesis and spine formation in the prefrontal cortex via stimulation of the mammalian target of the rapamycin signaling pathway, reversing stress-induced atrophy and producing rapid antidepressant effects. |
|
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.
2021
|
open-label study |
24 |
↕Mixed
|
Psilocybin therapy increased cognitive flexibility for at least four weeks, but greater increases in neural flexibility between the ACC and PCC were associated with less improvement in cognitive flexibility. |
|
LSD-induced entropic brain activity predicts subsequent personality change.
2016
|
balanced-order, placebo-controlled study |
19 |
↑Supports
|
LSD-induced increases in brain entropy predicted lasting increases in the personality trait openness two weeks later, especially during music listening and when ego dissolution was reported. |
|
Towards an understanding of psychedelic-induced neuroplasticity.
2023
|
review |
|
↑Supports
|
Psychedelics promote neuroplasticity through mechanisms including dendritogenesis, synaptogenesis, neurogenesis, and expression of plasticity-related genes, particularly in the prefrontal cortex and hippocampus. |
|
Effective connectivity changes in LSD-induced altered states of consciousness in humans.
2019
|
double-blind, randomized, placebo-controlled, cross-over study |
25 |
↑Supports
|
LSD increased effective connectivity from the thalamus to the posterior cingulate cortex via serotonin 2A receptor activation and decreased connectivity from the ventral striatum to the thalamus independently of those receptors. |
|
Network dysregulation in depression: A synthesis of HPA Axis, BDNF signaling, and neurotransmitter interactions across multidimensional systems.
2026
|
review |
|
↑Supports
|
The BDNF/CREB signaling pathway serves as a core hub mediating multisystem network dysfunction in depression, integrating emotional-cognitive circuits, HPA axis activity, neurotransmitter systems, and neuroplasticity. |
|
Classic psychedelics and autism spectrum disorder: preclinical evidence, mechanistic insights and unresolved challenges.
2026
|
review |
|
?Unclear
|
Classic psychedelics affect behavioral domains overlapping with ASD phenotypes through neurobiological mechanisms that converge with alterations implicated in ASD, but direct evidence from validated animal models of ASD is scarce. |
|
Antidepressant-like effects of ketamine involve CX3CL1/CX3CR1 signaling-mediated synaptic plasticity in the mPFC
2026
|
animal study |
|
↑Supports
|
Blocking CX3CL1/CX3CR1 signaling prevents ketamine's antidepressant-like behavioral effects and its enhancement of synaptic plasticity in mice. |
|
Psychedelic drug action at dendrites is gated by behavioral state and serotonin receptors
2026
|
experimental study |
|
↑Supports
|
Psilocybin transiently increases dendritic calcium event rates in apical tufts in a brain state- and 5-HT2A receptor-dependent manner, and alters the predictive relationship between acute dendritic calcium signaling and subsequent spine formation. |
|
Post-Perturbation Integrative Neuroplasticity (PPIN): A Descriptive Framework for Non-Pathological Cross-Domain Cognitive Reorganization
2026
|
theoretical or philosophical paper |
|
?Unclear
|
Proposes a descriptive framework, Post-Perturbation Integrative Neuroplasticity, to characterize broad cross-domain cognitive reorganization following significant perturbation events, distinguishing it from pathological conditions and post-traumatic growth. |
|
Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of Depression
2026
|
review |
|
↑Supports
|
Ketamine and esketamine have the strongest evidence among rapid-acting antidepressant interventions for treatment-resistant depression, while psilocybin-assisted therapy shows promise but remains investigational. |
|
Psilocybin's effect on human brain synaptic plasticity.
2026
|
observational cohort |
15 |
↕Mixed
|
Psilocybin's effect on synaptic density is modulated by environmental context, with a therapeutic-like setting associated with greater increases in synaptic density and more intense mystical-type experiences than an MRI scanner setting. |
|
Brain-targeted epigenetic effects of two emerging psychoplastogens: ketamine & MDMA
2026
|
clinical trial |
36 |
↑Supports
|
Ketamine and MDMA induce peripheral DNA methylation changes that converge on neuroplasticity and neuroimmune pathways. |
|
Treating addiction with an addictive drug: the ketamine paradox revisited
2026
|
narrative review |
|
↕Mixed
|
Ketamine combined with psychotherapy shows promising reductions in craving and increases in abstinent days for alcohol and cocaine use disorders, but effects on relapse prevention are inconsistent and the drug carries a well-established risk of misuse. |
|
Exploring neural underpinning of Christian faith: How far can we go?
2026
|
theoretical or philosophical paper |
|
?Unclear
|
Proposes that Christian commitment and practice may yield dedicated neural structures or networks over time and foster interplay with secular cognition, and outlines hypotheses and methods to test this. |